Select your language

Other official information and services: www.belgium.be  Logo Belgium

The following page reports data on acute respiratory infections (ARI), severe acute respiratory infections (SARI), influenza-like illness (ILI), flu, COVID-19, and RSV during the 2024-2025 season. We invite you to consult the results from previous seasons and to follow real-time updates on this page.

1. Key messages

  • The 2024–2025 flu season was notably intense and more prolonged compared to previous years.
  • Regarding SARS-CoV-2, the season was characterised initially by two waves in the summer and autumn of 2024 and ended with a period of lower intensity.
  • Compared with the previous season, the 0–5-month age group was significantly less affected by the RSV epidemic. This observation is consistent with the launch of the first immunization campaign (Nirsevimab) for young children in Belgium.

2. Syndromic surveillance

During the 2020-2021 and 2021-2022 seasons, health measures were put in place to stop the spread of the SARS-CoV-2 virus. These measures also reduced other respiratory infections. From spring 2022, more respiratory viruses other than SARS-CoV-2 began to circulate again in the population.

The 2024-2025 season extended from week 25 of 2024 (17 June) to week 24 of 2025 (15 June).

During the 2024–2025 season, the number of new ILI cases reached its highest level recorded in 10 years

During the 2024–2025 season, general practitioner (GP) consultations for influenza-like illness (ILI) peaked at 1,233 per 100,000 in the last week of January 2025, far above the previous season’s 638 per 100,000. Consultations for other acute respiratory infections (ARI) also peaked in the same week, although remaining below the low-activity threshold. This coincided with the flu epidemic. The second COVID-19 wave (mid-September to mid-October 2024) slightly affected ILI consultations but stayed below the low-activity threshold.

  • ILI
  • Other ARI

Weekly number of new cases for 100,000 inhabitants of GP consultations for ILI, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel general practitioners [1]

Weekly number of new cases for 100,000 inhabitants of GP consultations for other ARI, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel general practitioners [1]

During the 2024–2025 season, the number of new ILI consultations was highest in young children

During the 2024–2025 season, the number of new consultations for influenza-like illness (ILI) was highest among 0–14-year-olds, and lowest among individuals aged 65 years and older, which nevertheless represents a larger proportion of the Belgian population than children. Within the 0–14 age group, the number of consultations for acute respiratory infections (ARI), other than ILI, was higher in children aged 0 to 4 years than in those aged 5 to 14 years, but this was not observed for consultations for ILI. 

  • ILI
  • Other ARI

Weekly number of new cases for 100,000 inhabitants of GP consultations for ILI, by age group, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel general practitioners [1]

Weekly number of new cases for 100,000 inhabitants of GP consultations for other ARI, by age group, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel general practitioners [1]

SARI hospitalizations in the 2024-2025 season followed a similar pattern to last season

Hospitalizations for severe acute respiratory infections (SARI) followed a pattern similar to the previous season. Three peaks were observed: one in mid-December 2024 during the RSV epidemic, a second in late January 2025 at the height of the flu epidemic, and a third in mid-February 2025.

Weekly number of new cases for 100,000 inhabitants of patients hospitalized for SARI, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel hospitals [2]

Children aged 0–4 had the highest hospitalization rates, while older adults experienced more severe outcomes

Children aged 0–4 had the highest hospitalization rates, with a peak in mid-December, coinciding with the RSV epidemic. Older adults had lower rates but more severe outcomes. Winter 2024–2025 saw an excess mortality (+1.9%), especially among those 85+, coinciding with flu and RSV epidemics, smog, and a cold wave [3].

Weekly number of new cases for 100,000 inhabitants of patients hospitalized for SARI, by age group, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel hospitals [2]

3. Flu

The flu season reached its peak in late January 2025

The flu epidemic began in mid-December 2024 (week 50) and lasted until early March 2025 (week 10). It reached a peak of 692 confirmed cases per 100,000 inhabitants in late January 2025 (week 4). Around 540,000 people were affected by influenza-like illness (ILI) caused by flu during the 2024–2025 season in Belgium, representing about 5% of the total population.

For this season, the effectiveness of seasonal flu vaccines in Belgium was estimated at 44% for preventing GP consultations and 17% for preventing hospitalizations.

Weekly number of new cases for 100,000 inhabitants of GP consultations for influenza-like illness caused by flu, Belgium, 2024-2025 season 
Source: Sciensano, network of sentinel general practitioners [1]

The 2024–2025 flu season in Belgium was long and particularly intense

The epidemic lasted an unusually long 13 weeks and was exceptionally intense, with more than 4,500 cases per 100,000 inhabitants reported over the entire season—higher than any total recorded in the previous 10 years.

Seasonal number of new cases for 100,000 inhabitants of GP consultations for influenza-like illness caused by flu, Belgium, 2014/2015 - 2024/2025 seasons
Source: Sciensano, network of sentinel general practitioners [1]

Hospitalizations for flu-confirmed SARI peaked in mid-January 2025, with 15% experiencing severe complications

During the 2024–2025 season, the peak of hospital admissions for flu-confirmed SARI occurred in mid-January (weeks 3 and 4). The maximum new cases during this season were slightly higher than in the previous season. However, due to changes introduced in the SARI surveillance system in 2023, including increased coverage, improved data quality, and shorter reporting delays, comparisons between seasons should be interpreted with caution.

During this winter season, 15% of patients hospitalized with flu-confirmed SARI experienced severe complications. Among those patients, 4% died.

Weekly number of new cases for 100,000 inhabitants of patients hospitalized for SARI, positive for flu, Belgium, 2024–2025 season
Source: Sciensano, sentinel hospital network [2]

4. COVID-19

No COVID-19 wave was observed during the winter of 2024-2025

The year 2024 was marked by two waves of SARS-CoV-2 during the summer (mid-June - beginning of August 2024) and in autumn (mid-September – mid-October 2024), with moderate intensity compared to the waves observed in the previous year (December 2023). The first part of 2025 saw a new, smaller SARS-CoV-2 wave. During this season 2024-2025 , three COVID-19 waves were thus observed. From the end of October 2024 till the end of the season, about 25,000 COVID-19 cases were confirmed in Belgium.

Weekly number of new cases for 100,000 inhabitants of suspected and confirmed COVID-19 infections, Belgium, 2024-2025 season
Source: COVID-19 barometer of general practitioners [4]
Data on general practitioner consultations for suspected or confirmed COVID-19 come from the new GP infection barometer, which started in October 2024; as a result, data are not available from the very beginning of the season.

Hospitalizations for SARS-CoV-2–confirmed SARI were lower during the 2024–2025 season compared to previous seasons

The highest number of new hospitalizations with confirmed COVID-19 recorded by the SARI network was observed during the first wave of the season, with 3.1 hospitalizations per 100,000 inhabitants for SARS-CoV-2 in mid-September 2024, a value lower than those observed at the peaks of waves during the two previous seasons.

Caution is advised when interpreting age-specific trends in SARI COVID-19 infections, as the weekly number of positive samples is low. Nevertheless, it is observed that the age groups with the highest number of new cases among hospitalized SARI patients with confirmed SARS-CoV-2 infection are 0–4 years and 65 years and older.

Among SARI patients who tested positive for SARS-CoV-2, 12% experienced severe complications during the first wave (mid-June to end of July) of the season, and 16% experienced severe complications during the second wave (mid-September to mid-October).

The available data show that in Belgium, COVID-19 vaccination prevented 52% of hospitalizations among adults aged over 65 years during the 2024–2025 winter season.

Weekly number of patients hospitalized for SARI for 100,000 inhabitants, positive for SARS-CoV-2, Belgium, 2024-2025 season
Source: Sciensano, sentinel hospital network [2]

5. Respiratory Syncytial Virus

The 2024–2025 RSV epidemic followed a typical seasonal pattern in Belgium

The RSV epidemic lasted 12 weeks, extending from week 46 (mid-November 2024) to week 05 (early February 2025). The peak of the epidemic was reached in week 50 (December 2024), with 969 positive tests reported. However, these positive samples were reported by participating sentinel laboratories and do not represent the national total.

The profile of this epidemic (in terms of intensity and duration) is consistent with what is typically observed in Belgium.

Weekly number of RSV-positive samples, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel laboratory [5]
The positive samples are reported by participating sentinel laboratories and do not represent the national total.

Most positive samples are detected in children aged 0–4 years

By age group, the majority of RSV-positive samples were detected in the youngest group—children aged 0 to 4 years—during the 2024-2025 season. Young children were the most affected by RSV infection and therefore the most frequently tested for this pathogen.

There is a clear difference in the timing of the epidemic between young children and adults. While young children experienced an earlier peak at the end of November, the older age group reached their peak later, at the beginning of January.

Weekly number of RSV-positive samples, by age group, Belgium, 2024-2025 season
Source: Sciensano, network of sentinel laboratory [5]
The positive samples are reported by participating sentinel laboratories and do not represent the national total. Age-specific data should be interpreted with caution due to potential bias from the testing strategy.

The 2024–2025 RSV season saw a high peak in confirmed SARI hospital admissions

The number of new hospitalized patients (SARI) positive for RSV peaked at 6.6 hospitalizations per 100,000 inhabitants in late November to early December, representing a higher intensity than in the previous two seasons. However, differences between seasons should be interpreted with caution due to the significant changes implemented in SARI surveillance in November 2023. This peak was almost entirely driven by the 0–4 years age group.

Among SARI patients positive for RSV, 9.3% experienced severe complications during the epidemic (mid-November – end of January). In the 0–4 years age group, 6.4% of hospitalized children with SARI positive for RSV experienced severe complications during the epidemic.

Weekly number of new patients hospitalized for SARI per 100,000 inhabitants, positive for RSV, Belgium, 2024-2025 season
Source: Sciensano, sentinel hospital network [2]

The RSV immunisation effectively reduced hospitalizations among the youngest children

Focusing specifically on RSV hospitalizations among young children, the burden was highest in those under 1 year of age. Compared to the previous season, the 0–5-month age group was notably less affected by the epidemic. This observation aligns with the launch of the first immunization campaign (Nirsevimab) for young children in Belgium. The effectiveness of RSV immunization against hospitalization among children under 4 years of age was estimated at 86% for the 2024–2025 season.

Weekly number of new hospitalized SARI patients with confirmed RSV per 100,000 inhabitants in each age group (0–4 years), Belgium, 2024–2025 season
Source: RSVPed [6]

6. Read more

View the metadata for this indicator

Epsitat dashboard Sciensano – epidemiology of infectious diseases

Results of the surveillance of flu and influenza-like illness in Belgium 

The weekly flu bulletin for the current flu season

Background

Since spring 2022, an increasing number of respiratory viruses other than SARS-CoV-2 have resumed circulation in the population. During the 2024–2025 season, the incidence of acute respiratory infections followed a seasonal trend—rising in the fall, remaining high throughout the winter, and declining in the spring—marked by the overlapping circulation of various respiratory pathogens, including flu, SARS-CoV-2, and RSV.

Influenza-like illness (ILI) refers to a group of symptoms that suggest a viral respiratory infection, including fever, chills, dry cough, fatigue, and muscle aches. These symptoms can be caused by various viruses, such as flu, RSV, adenovirus, parainfluenza, or SARS-CoV-2. Seasonal flu is caused by Influenza viruses type A and B, which circulate each winter and are known for frequent mutations. This variability requires the vaccine to be updated regularly. Most people recover within a couple of weeks, but serious complications may occur in high-risk groups, including the elderly, people with chronic diseases, pregnant women, and very young children [7].

SARS-CoV-2, the virus responsible for COVID-19, emerged in late 2019 and caused a global pandemic. It spreads mainly through respiratory droplets and aerosols. The severity of illness varies depending on the variant and individual immunity. During the 2020–2021 and, to a lesser extent, the 2021–2022 seasons, public health measures (e.g. mask use, distancing) helped reduce not only COVID-19 transmission but also the spread of other respiratory viruses. In May 2023, the WHO declared the end of COVID-19 as a public health emergency of international concern, leading to changes in testing strategies [7].

Respiratory syncytial virus (RSV) is a common cause of respiratory illness in young children but can also affect adults—especially older adults or those with weakened immune systems. RSV is highly contagious and spreads via droplets. In Belgium, RSV typically circulates from October to March, with peaks in December or January. Since 2024 immunization of infants with monoclonal antibodies and maternal vaccination has been available in Belgium. Since 2025, vaccination has also been offered to the elderly and adults with comorbidities [7].

In Belgium, the surveillance of acute respiratory infections is coordinated by Sciensano. It relies on several sentinel networks, including general practitioners, laboratories and hospitals. These networks report weekly on the number of ILI and SARI cases. Differences between seasons should be interpreted with caution for SARI, given significant changes made to SARI surveillance in November 2023, which improved paediatric RSV surveillance. Surveillance of ILI is also carried out by a sentinel network of nursing homes, which assesses the number of ILI cases, hospitalizations and ILI-related deaths. Virological surveillance helps assess the circulation of seasonal flu, SARS-CoV-2, and RSV. In addition, flu, SARS-CoV-2, and RSV are also monitored through wastewater surveillance [7].

The Be-MOMO surveillance system is used to quantify excess mortality that may result from epidemics such as flu, COVID-19, and RSV.

Definitions

Acute Respiratory Infection (ARI)
Sudden/acute onset of respiratory symptoms, with or without fever or malaise, including a wide range of episodes such as colds, rhinitis, (rhino-)pharyngitis, tonsillitis, sinusitis, acute otitis media, laryngitis, (laryngo-)tracheitis, bronchitis, bronchiolitis, and (broncho)pneumonia, but excluding influenza-like illnesses (ILI).
Influenza-like illness (ILI)
ILI can be caused by a variety of microbial agents other than flu viruses. ILI is defined as an acute respiratory infection with sudden onset of fever, respiratory and general symptoms, such as general malaise or muscle pain.
Flu
Flu, or influenza, is a contagious infectious disease caused by the influenza virus (influenzavirus). The disease is characterized by the development of a flu-like syndrome. This refers to a combination of symptoms commonly associated with the illness, including: fever, chills, malaise, dry cough, loss of appetite, muscle aches and nausea.
COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that causes COVID-19. Symptoms of COVID-19 can vary widely, ranging from mild to severe, and may include fever, cough, difficulty breathing, loss of taste or smell, and fatigue. While many individuals recover without needing specialized treatment, COVID-19 can lead to serious complications, particularly in vulnerable populations.
Respiratory Synctitial Virus (RSV)
Symptoms usually appear 4 to 6 days after exposure (range: 2 to 8 days). RSV infection most often causes upper respiratory tract symptoms, which, in severe cases, may progress to lower respiratory tract illness. In infants, RSV is the leading cause of bronchiolitis and one of the main causes of hospitalization.
Severe Acute Respiratory Infection (SARI)
SARI is defined as a severe form of acute respiratory infection requiring hospitalisation for at least 24 hours. The case definition includes the presence of at least two acute respiratory symptoms (fever ≥ 38°C or history of fever, cough, respiratory distress such as dyspnoea, or abnormal lung auscultation). In children under 5 years of age, apnoea or cyanosis are also considered qualifying symptoms.
Severe complications
Among SARI patients, severe complications included death, acute respiratory distress syndrome (ARDS), admission to intensive care units (ICU), use of extracorporeal membrane oxygenation (ECMO), or invasive mechanical ventilation.

References

  1. Sciensano. Network of sentinel general practitioners. https://www.sciensano.be/fr/projets/reseau-de-medecins-generalistes-vigies
  2. Sciensano. Sentinel hospital network. https://www.sciensano.be/fr/projets/severe-acute-respiratory-infection-surveillance-par-un-reseau-dhopitaux-vigies
  3. Sciensano. The Belgian Mortality Monitoring. https://www.sciensano.be/fr/projets/belgian-mortality-monitoring 
  4. Sciensano. COVID-19 barometer in general practitioner. Belgium. https://www.sciensano.be/en/covid-19-barometer-general-practices
  5. Sciensano. Network of sentinel laboratory or Epilabo. Belgium. https://www.sciensano.be/en/network-sentinel-laboratories-epilabo
  6. Sciensano. RSVPed. Belgium
  7. Sciensano. Surveillance des infections respiratoires aiguës : rapport épidémiologique saison 2024-2025. Belgium. https://www.sciensano.be/fr/biblio/surveillance-des-infections-respiratoires-aigues-rapport-epidemiologique-saison-2024-2025

Please cite this page as: Sciensano. Communicable diseases: Acute respiratory infections, Health Status Report, 8 April 2026, Brussels, Belgium.